What is a triple-negative breast cancer?
Triple-negative breast cancer is a type of breast cancer is the most common.
To understanding triple-negative breast cancer, someone needs to find out more about the three main types of breast cancer. This is:
estrogen receptor positive
progesterone receptor positive
Progesterone receptor positive and positive estrogen receptor is a type of breast cancer is the most common.
For people who develop one of these types of cancer, there is a choice of hormonal therapy that can help attack the cancer cells. If single therapy is not successful, often other therapies might be.
Another common type of breast cancer is HER2 receptor positive. In the case of HER2 cancer cells have many HER2 receptors on its surface. Similar to breast cancer causing by hormone receptor HER2, breast cancer can be treated with different therapeutic that targets HER2 receptors.
Triple-negative breast cancer refers to cancer that has not tested positive for any of the three other types. This is also the most common form of breast cancer and the most difficult to treat.
Unlike the three main types, triple-negative breast cancer don’t have a targeted therapy, currently. It is also more likelier than other types of breast cancer to spread and relapse.
Currently, the researchers are interested in knowing more about the risk factors for developing breast cancer-triple negative. Those who have been identified by researchers so far include:
Obesity and inactivity
People who are obese and have higher BMI found higher risk exposed to triple-negative breast cancer. These categories are likely to include those who are not very active.
The individual with the gene mutation has a higher risk for triple-negative breast cancer, as well as other common cancers.
A family history of breast cancer can help determine if a person is exposed to a higher risk of breast cancer in the future.
The age of.
Some research suggests that age may play a role in increasing the risk of developing breast cancer-triple negative.
Premenopausal women have been found to develop triple-negative breast cancer more oftener than postmenopausal women.
Race or ethnicity.
Some research suggests that certain backgrounds can make people more susceptible to triple-negative breast cancer. A number of cases of triple-negative breast cancer that disproportionately affects African American women.
Some research suggests that if a woman ever conceived a role in raising or lowering the risk of triple-negative breast cancer.
Women who have children tended to be more riskier than those who do not have children. Similarly, women who have only one child tend to develop triple-negative breast cancer compared to women with many children.
A mammogram can be used to diagnose triple-negative breast cancer.
Diagnosis of triple-negative breast cancer starts with detection.
Like other breast cancer, one might feel a small hard lump in or near their breasts. In other cases, scanning the breasts on a regular basis can reveal areas of concern.
After growth is detected, the doctor will need to take tissue samples from it. In many cases, this is done with a needle to extract samples from a suspected lump. Samples sent to the lab for further testing.
Laboratory of pathology report will return to the doctor that details about what that growth. In some cases it’s benign, meaning that there is no cancer cells. Other times, the pathology report shows that it is cancerous.
What type of breast cancer a person will be highlighted by the pathology report as well. Someone who kankernya does not match one of the three main categories will receive a diagnosis of triple-negative breast cancer.
Chemotherapy is one of the few treatments available for triple-negative breast cancer.
Treatment options for triple-negative breast cancer limited compared to what is available for other types of breast cancer.
Hormone therapy found less effective because this type of cancer is not affected by the three hormones associated with other breast cancer.
However, several options are available, and researchers are looking for additional medications to help treat breast cancer more aggressive.
Currently, treatment options for triple-negative breast cancer include:
Selection of operations including removal of part or one or both breasts. Someone in the early stages of triple-negative breast cancer might not want to consider mastectomy, as first-line treatment.
In the case any further, the doctor may recommend a mastectomy to remove the cancer before it spreads.
Radiation is another potential treatment for people with triple-negative breast cancer. Radiation target and kill cancer cells to stop growing and its spread.
Studies show that chemotherapy probably the best treatment option for triple-negative breast cancer.
General treatment plan should be developed between individuals and their doctors. Such a plan should elaborate on what steps to be taken to treat the cancer, the treatments themselves, and what should be done if the cancer does not respond to treatment or began to spread.
An important part of treatment is to make someone stays active and eat a variety of healthy foods. Improve the diet and exercise can help a person feel better during treatment.
The researchers described the prospects for cancer in the 5-year survival rate. In the case of triple-negative breast cancer, people tend to survive the first five years after diagnosis than those diagnosed with other types of breast cancer.
However, survival and overall prognosis varies from person to person. Many factors can influence the prognosis of individuals, including:
When cancer is found and treated
What stage of cancer it is and whether it has spread or not
How does cancer respond to treatment
In cases where the cancer was caught at an early stage and treated effectively, a person has a survival rate that is much higher than if found on the next stage, where the cancer has spread or do not respond to treatment.